In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: Effect of topical corticosteroids

Clinical and Experimental Allergy

Volumn 30, Issue 1, 2000, Pages 86-93

  Ghaffar, O ^a   Christodoulopoulos, P ^a   Lamkhioued, B ^a   Wright, E ^a,b   Ihaku, D ^a   Nakamura, Y ^a   Frenkiel, S ^b,c   Hamid, Q ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Allergic rhinitis; Interleukin 4; Interleukin 4 receptor; Late nasal response; STAT6; Steroids; TH2 cells

Indexed keywords

ALLERGEN; CORTICOSTEROID; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; PLACEBO; STAT6 PROTEIN;

ALLERGIC RHINITIS; ARTICLE; ATOPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; EOSINOPHILIA; FACIAL BONE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRANASAL; ALLERGENS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD3; BLOOD PROTEINS; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-4; LYMPHOCYTE COUNT; NASAL MUCOSA; RHINITIS, ALLERGIC, SEASONAL; RIBONUCLEASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; STEROIDS; T-LYMPHOCYTES; TRANS-ACTIVATORS;

EID: 0033975489     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00781.x     Document Type: Article

References (42)

1. 1 Robinson DS, Hamid Q, Jacobson M, Ying S, Kay AB, Durham SR. Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Sem Immunopathol 1993; 15:17-27.
2. 2 Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13:501-7.
3. + T cells in brown Norway rats. J Clin Invest 1995; 96:1303-10.
4. + cells in the pathogenesis of allergic diseases. Proc Soc Exp Biol Med 1997; 215:11-20.
5. 5 Varney VA, Jacobson MR, Sudderick RM et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis: identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 1992; 146:170-6.
6. 6 Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390-4.
7. 7 Ghaffar O, Laberge S, Jacobson S et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 and modulation by topical glucocorticoids. Am J Respir Cell Mol Biol 1997; 17:17-24.
8. 8 Ying S, Durham SR, Jacobson MR et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994; 82:200-6.
9. 9 Ying S, Durham SR, Barkans J et al. T cells are the principle source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993; 9:356-60.
10. 10 Masuyama K, Jacobson MR, Rak S et al. Topical glucocorticoid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994; 82:192-9.
11. 11 Rolfe FG, Hughes JM, Armour CL, Sewell WA. Inhibition of IL-5 gene expression by dexamethasone. Immunology 1992; 77:494-9.
12. 12 Brusselle G, Kips J, Joos G, Bluethmann H, Pauwels R. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4 deficient mice. Am J Respir Cell Mol Biol 1995; 12:254-9.
13. 13 Gavett SH, O'Hearn DJ, Karp CL et al. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol 1995; 272:L253-1.
14. 14 Lukacs NW, Strieter RM, Chensue SW, Kunkel SL. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am J Respir Cell Mol Biol 1994; 10:526-32.
15. 15 Del Prete GF, Maggi E, Parronchi P et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140:4193-8.
16. 16 Swain SL, Weinberg AD, Inglish M, Hutson G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145:3796-806.
17. 17 Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79:3101-9.
18. 18 Schleimer RP, Sterbinsky SA, Kaiser J et al. IL-4-induced adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992; 148:1086-92.
19. 19 Temann UA, Prasad B, Gallup MW et al. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 1997; 16:471-8.
20. 20 Guo FH, Uetani K, Haque SJ et al. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest 1997; 100:829-38.
21. 21 Nakaniura Y, Azuma M, Okano Y et al. Upregulatory effect of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte-macrophage stimulatory factor production by human bronchial epithelial cells. Am J Respir Cell Mol Biol 1996; 15:680-7.
22. 22 Rothenberg ME, Luster AD, Leder P. Murine eotaxin: an eosinophil chemoattractant induced in endothelial cells and IL-4-induced tumour suppression. Proc Natl Acad Sci USA 1995; 92:8960-4.
23. 23 Keegan AD, Nelms K, Wang LM, Pierce JH, Paul WE. Interleukin-4 receptor: signalling mechanism. Immunol Today 1994; 15:423-32.
24. 24 Wright ED, Frenkiel S, Small P, Christodoulopoulos P, Hamid Q. Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids. Otolaryngol Head Neck Surg 1998; 118:804.
25. 25 Kotsimbos TC, Ghaffar O, Minshall EM et al. Expression of IL-4 receptor α subunit is increased in bronchial biopsy specimens from atopic and non-atopic asthmatic subjects. J Allergy Clin Immunol 1998; 102:859-66.
26. 26 Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995; 64:621-51.
27. 27 Takeda K, Kishimoto T, Akira S. Stat6: its role in interleukin-4 mediated biological functions. J Mol Med 1997; 75:317-26.
28. 28 Sun XJ, Wang LM, Zhang Y et al. Role of IRS2 in insulin and cytokine signalling. Nature 1995; 377:173-7.
29. 29 Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996; 4:313-9.
30. 30 Shimoda K, Van Deurson J, Sangster MY et al. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380:630-3.
31. 31 Takeda K, Tanaka T, Shi W et al. Essential role of Stat6 in IL-4 signalling. Nature 1996; 380:627-30.
32. 32 Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (Stat6) - deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998; 187:939-48.
33. 33 Akimoto T, Numata F, Tamura M et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT) 6 deficient mice. J Exp Med 1998; 187:1537-42.
34. 34 Giaid A, Michel RP, Stewart DJ, Shepperd H, Corrin B, Hamis Q. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 1993; 341:1550-4.
35. 35 Giaid A, Hamid Q, Adams C, Springall DR, Terenghi G, Polak JM. Comparison between different labels and detection systems. Histochemistry 1989; 93:191-6.
36. 36 Ohmori Y, Hamilton TA. IL-4-induced Stat6 suppresses IFN-gamma-stimulated Stat1-dependent transcription in mouse macrophages. J Immunol 1997; 159:5474-82.
37. 37 Hershey GK, Freidrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N Engl J Med 1997; 337:1720-5.
38. 38 Mitsuyasu H, Izuhara K, Mao X-Q, Gao P-S, Arinobu Y, Enomoto T. Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma. Nature Genet 1998; 19:119-20.
39. 39 Patel BKR, Pierce JH, LaRochelle WJ. Regulation of interleukin-4-mediated signalling by naturally occurring dominant negative and attenuated forms human Stat6. Proc Natl Acad Sci USA 1998; 95:172-7.
40. 40 Mascareno E, Dhar M, Siddiqui MAQ. Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promotor - a cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci USA 1998; 95:5590-4.
41. 41 Karras JG, Wang ZH, Huo L, Frank DA, Rothstein TL. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes - distinct STAT activation following surface Ig and CD40 receptor engagement. J Immunol 1997; 159:4350-5.
42. 42 Barnes PJ, Karin M. Nuclear factor κB: a pivotal transcription factor in chronic inflammatory diseases. New Engl J Med 1997; 336:1066-71.